-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NMMb/IRACeLSYnHnXZIoZOSJDGju90eqwzJScG2FaQaomGKEp78BbbAYQTspnNtE w+17N+BwFdeYmtNxGOpL/A== 0000950135-01-000582.txt : 20010223 0000950135-01-000582.hdr.sgml : 20010223 ACCESSION NUMBER: 0000950135-01-000582 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20010214 GROUP MEMBERS: ATLAS VENTURE ASSOCIATES V, INC. GROUP MEMBERS: ATLAS VENTURE ASSOCIATES V, L.P. GROUP MEMBERS: ATLAS VENTURE ENTREPRENUERS' FUND V, L.P. GROUP MEMBERS: ATLAS VENTURE FUND V LP GROUP MEMBERS: ATLAS VENTURE FUND V, L.P. GROUP MEMBERS: ATLAS VENTURE PARALLEL FUND V-A, C.V. GROUP MEMBERS: ATLAS VENTURE PARALLEL FUND V-B, C.V. GROUP MEMBERS: CHRISTOPHER J. SPRAY GROUP MEMBERS: JEAN-FRANCOIS FORMELA GROUP MEMBERS: RONALD NORDIN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-60711 FILM NUMBER: 1539122 BUSINESS ADDRESS: STREET 1: 490 SAN ANTONIO RD STREET 2: STE 201 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 6504963770 MAIL ADDRESS: STREET 1: 490 SAN ANTONIO ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ATLAS VENTURE FUND V LP CENTRAL INDEX KEY: 0001106910 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 043500803 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 222 BERKELEY ST CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6178599290 SC 13G 1 b38256cbsc13g.txt CIPHERGEN BIOSYSTEMS, INC. 1 ---------------------------- OMB APPROVAL ---------------------------- OMB Number: 3235-0145 Expires: October 31, 2002 Estimated average burden hours per response ... 14.90 ---------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )* CIPHERGEN BIOSYSTEMS, INC. ----------------------------------------------------------- (Name of Issuer) COMMON STOCK, $.001 par value ----------------------------------------------------------- (Title of Class of Securities) 17252Y104 ----------------------------------------------------------- (CUSIP Number) ----------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) / / Rule 13d-1(c) /X/ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 Page 2 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Fund V, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 2 of 21 3 Page 3 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Entrepreneurs' Fund V, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 3 of 21 4 Page 4 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Parallel Fund V-A, C.V. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION The Netherlands - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 4 of 21 5 Page 5 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Parallel Fund V-B, C.V. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION The Netherlands - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 5 of 21 6 Page 6 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Associates V, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 6 of 21 7 Page 7 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Associates V, Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Corporation - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - -------------------------------------------------------------------------------- Page 7 of 21 8 Page 8 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Christopher J. Spray - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- Page 8 of 21 9 Page 9 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Jean-Francois Formela - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION France - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 11,300 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 11,300 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,643,982 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- Page 9 of 21 10 Page 10 of 21 CUSIP NO. 17252Y104 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ronald Nordin - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 shares NUMBER OF ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 1,632,682 shares ----------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 shares ----------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,632,682 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,632,682 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- Page 10 of 21 11 Schedule 13G Item 1(a). Name of Issuer: Ciphergen Biosystems, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 6611 Dumbarton Circle, Fremont, CA 94555 Item 2(a). Names of Persons Filing: Atlas Venture Fund V, L.P., Atlas Venture Entrepreneurs' Fund V, L.P., Atlas Venture Parallel Fund V-A, C.V., Atlas Venture Parallel Fund V-B, C.V., Atlas Venture Associates V, L.P., Atlas Venture Associates V, Inc., Christopher J. Spray, Jean-Francois Formela and Ronald Nordin. Atlas Venture Associates V, Inc. is the sole general partner of Atlas Venture Associates V, L.P. Atlas Venture Associates V, L.P. is the sole general partner of Atlas Venture Fund V, L.P., Atlas Venture Entrepreneurs' Fund V, L.P., Atlas Venture Parallel Fund V-A, C.V. and Atlas Venture Parallel Fund V-B, C.V. Messrs. Spray, Formela and Nordin are directors of Atlas Venture Associates V, Inc. Item 2(b). Address of Principal Business Office or, if None, Residence: The address of the principal business office of Atlas Venture Fund V, L.P., Atlas Venture Entrepreneurs' Fund V, L.P., Atlas Venture Parallel Fund V-A, C.V., Atlas Venture Parallel Fund V-B, C.V., Atlas Venture Associates V, L.P., Atlas Venture Associates V, Inc. and Messrs. Spray, Formela and Nordin is Atlas Venture, 222 Berkeley Street, Boston, Massachusetts 02116. Item 2(c). Citizenship: Atlas Venture Fund V, L.P., Atlas Venture Entrepreneurs' Fund V, L.P. and Atlas Venture Associates V, L.P. are each a limited partnership organized under the laws of the State of Delaware. Atlas Venture Associates V, Inc. is a corporation organized under the laws of the State of Delaware. Atlas Venture Parallel Fund V-A, C.V. and Atlas Venture Parallel Fund V-B, C.V. are each a Limited Partnership organized under the laws of The Netherlands. Mr. Spray is a citizen of the United Kingdom. Mr. Formela is a citizen of France. Mr. Nordin is a citizen of the United States. Item 2(d). Title of Class of Securities: Common Stock, $.001 par value. Item 2(e). CUSIP Number: 17252Y104. Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not Applicable. Item 4. Ownership. (a) Amount Beneficially Owned: Page 11 of 21 12 Each of Atlas Venture Fund V, L.P., Atlas Venture Entrepreneurs' Fund V, L.P., Atlas Venture Parallel Fund V-A, C.V., Atlas Venture Parallel Fund V-B, C.V., Atlas Venture Associates V, L.P. and Atlas Venture Associates V, Inc. (individually an "Entity" and collectively the "Entities") may be deemed to own beneficially 1,632,682 shares of Common Stock as of December 31, 2000. Each of Messrs. Spray and Nordin may be deemed to own beneficially 1,632,682 shares of Common Stock as of December 31, 2000. Mr. Formela may be deemed to own beneficially 1,643,982 shares (including 7,000 shares and an option exercisable for 4,300 shares) of Common Stock as of December 31, 2000. As of December 31, 2000, Atlas Venture Fund V, L.P. is the record owner of 1,290,580 shares of Common Stock, Atlas Venture Entrepreneurs' Fund V, L.P. is the record owner of 21,482 shares of Common Stock, Atlas Venture Parallel Fund V-A, C.V. is the record owner of 160,310 shares of Common Stock, and Atlas Venture Parallel Fund V-B, C.V. is the record owner of 160,310 shares of Common Stock (referred to as the "Record Shares"). By virtue of the affiliate relationships among the Entities, each Entity may be deemed to own beneficially all of the Record Shares. Hence, each Entity may be deemed to own beneficially 1,632,682 shares of Common Stock. In their capacities as directors of Atlas Venture Associates V, Inc., each of Messrs. Spray and Nordin may be deemed to own beneficially 1,632,682 shares of Common Stock. Mr. Formela may be deemed to own beneficially 1,643,982 shares (including 7,000 shares and an option exercisable for 4,300 shares) of Common Stock as of December 31, 2000. (b) Percent of Class: Atlas Venture Fund V, L.P. 6.1% Atlas Venture Entrepreneurs' Fund V, L.P. 6.1% Atlas Venture Parallel Fund V-A, C.V. 6.1% Atlas Venture Parallel Fund V-B, C.V. 6.1% Atlas Venture Associates V, L.P. 6.1% Atlas Venture Associates V, Inc. 6.1% Christopher J. Spray 6.1% Jean-Francois Formela 6.1% Ronald Nordin 6.1%
The foregoing percentages are calculated based on the 26,729,889 shares of Common Stock reported to be outstanding in a Quarterly Report on Form 10-Q for Ciphergen Biosystems, Inc. for the Quarter ending September 30, 2000, as adjusted pursuant to Rule 13d-3(d)(1). (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Jean-Francois Formela 11,300 shares
0 shares as to each other reporting person. (ii) shared power to vote or to direct the vote: Page 12 of 21 13 Atlas Venture Fund V, L.P. 1,632,682 shares Atlas Venture Entrepreneurs' Fund V, L.P. 1,632,682 shares Atlas Venture Parallel Fund V-A, C.V. 1,632,682 shares Atlas Venture Parallel Fund V-B, C.V. 1,632,682 shares Atlas Venture Associates V, L.P. 1,632,682 shares Atlas Venture Associates V, Inc. 1,632,682 shares Christopher J. Spray 1,632,682 shares Jean-Francois Formela 1,632,682 shares Ronald Nordin 1,632,682 shares
(iii) sole power to dispose or to direct the disposition of: Jean-Francois Formela 11,300 shares
0 shares as to each other reporting person. (iv) shared power to dispose or to direct the disposition of: Atlas Venture Fund V, L.P. 1,632,682 shares Atlas Venture Entrepreneurs' Fund V, L.P. 1,632,682 shares Atlas Venture Parallel Fund V-A, C.V. 1,632,682 shares Atlas Venture Parallel Fund V-B, C.V. 1,632,682 shares Atlas Venture Associates V, L.P. 1,632,682 shares Atlas Venture Associates V, Inc. 1,632,682 shares Christopher J. Spray 1,632,682 shares Jean-Francois Formela 1,632,682 shares Ronald Nordin 1,632,682 shares
Each of the reporting persons expressly disclaims beneficial ownership of any shares of Common Stock of Ciphergen Biosystems, Inc., except in the case of (i) Atlas Venture Fund V, L.P. for the 1,290,980 shares which it holds of record; (ii) Atlas Venture Entrepreneurs' Fund V, L.P. for the 21,482 shares which it holds of record; (iii) Atlas Venture Parallel Fund V-A, C.V. for the 160,310 shares which it holds of record; (iv) Atlas Venture Parallel Fund V-B, C.V. for the 160,310 shares which it holds of record; and (v) Jean-Francois Formela for the 11,300 shares which he holds of record. Item 5. Ownership of Five Percent or Less of a Class. Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable. Item 8. Identification and Classification of Members of the Group. Not Applicable. The reporting persons expressly disclaim membership in a "group" as defined in Rule 13d-1(b)(1)(ii)(J). Page 13 of 21 14 Item 9. Notice of Dissolution of Group. Not Applicable. Item 10. Certifications. Not Applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b) or Rule 13d-1(c). Page 14 of 21 15 SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. We also hereby agree to file this statement jointly pursuant to the Agreement listed on Exhibit 1 hereto. Dated: February 13, 2001 ATLAS VENTURE FUND V, L.P. ATLAS VENTURE PARALLEL FUND V-B, C.V. By: Atlas Venture Associates V, L.P. By: Atlas Venture Associates V, L.P. General Partner General Partner By: Atlas Venture Associates V, Inc. By: Atlas Venture Associates V, Inc. By: * By: * ---------------------------- ----------------------- Christopher Spray Christopher Spray President President ATLAS VENTURE ENTREPRENEURS' FUND V, L.P. ATLAS VENTURE ASSOCIATES V, L.P. By: Atlas Venture Associates V, L.P. By: Atlas Venture Associates V, Inc. General Partner By: * --------------------------- By: Atlas Venture Associates V, Inc. Christopher Spray President By: * ---------------------------- Christopher Spray ATLAS VENTURE ASSOCIATES V, INC. President By: * --------------------------------- Christopher Spray President ATLAS VENTURE PARALLEL FUND V-A, C.V. * ------------------------------------ By: Atlas Venture Associates V, L.P. Christopher J. Spray General Partner * ------------------------------------ By: Atlas Venture Associates V, Inc. Jean-Francois Formela By * * ---------------------------- ------------------------------------ Christopher Spray Ronald Nordin President * The undersigned attorney-in-fact, by signing her name below, does hereby sign this statement on behalf of the above indicated filers pursuant to Powers of Attorney filed hereto as Exhibit 2. /s/ Jeanne Larkin Henry ------------------------------------ Jeanne Larkin Henry Attorney-in-fact Page 15 of 21 EX-99.1 2 b38256cbex99-1.txt AGREEMENT 1 Exhibit 1 AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Ciphergen Biosystems, Inc. This agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 13th day of February, 2001. ATLAS VENTURE FUND V, L.P. ATLAS VENTURE PARALLEL FUND V-B, C.V. By: Atlas Venture Associates V, L.P. By: Atlas Venture Associates V, L.P. General Partner General Partner By: Atlas Venture Associates V, Inc. By: Atlas Venture Associates V, Inc. By: * By: * ---------------------------- ----------------------- Christopher Spray Christopher Spray President President ATLAS VENTURE ENTREPRENEURS' FUND V, L.P. ATLAS VENTURE ASSOCIATES V, L.P. By: Atlas Venture Associates V, L.P. By: Atlas Venture Associates V, Inc. General Partner By: * --------------------------- By: Atlas Venture Associates V, Inc. Christopher Spray President By: * ---------------------------- Christopher Spray ATLAS VENTURE ASSOCIATES V, INC. President By: * --------------------------------- Christopher Spray President ATLAS VENTURE PARALLEL FUND V-A, C.V. * ------------------------------------ By: Atlas Venture Associates V, L.P. Christopher J. Spray General Partner * ------------------------------------ By: Atlas Venture Associates V, Inc. Jean-Francois Formela By * * ---------------------------- ------------------------------------ Christopher Spray Ronald Nordin President Page 16 of 21 2 * The undersigned attorney-in-fact, by signing her name below, does hereby sign this statement on behalf of the above indicated filers pursuant to Powers of Attorney filed hereto as Exhibit 2. /s/ Jeanne Larkin Henry ------------------------------------ Jeanne Larkin Henry Attorney-in-fact Page 17 of 21 EX-99.2 3 b38256cbex99-2.txt POWER OF ATTORNEY 1 Exhibit 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints each and any of Christopher J. Spray and Jeanne Larkin Henry his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities (until revoked in writing) to sign any and all instruments, certificates and documents required to be executed on behalf of himself individually or on behalf of each or any of Atlas Venture Fund, L.P., Atlas Venture Associates, L.P., Atlas Venture Partners III, B.V., Atlas Venture Fund II, L.P., Atlas Venture Associates II, L.P., Atlas Venture Europe Fund B.V., Atlas InvesteringsGroep N.V., Atlas Venture Beheer II B.V., Partno Deelmingen B.V., Atlas Venture Fund III, L.P., Atlas Venture Entrepreneurs' Fund III, L.P., Atlas Venture Associates III, L.P., Atlas Venture Associates III, Inc., Atlas Venture Fund V, L.P., Atlas Venture Entrepreneurs' Fund V, L.P., Atlas Venture Parallel Fund V-A, C.V., Atlas Venture Parallel Fund V-B, C.V., Atlas Venture Associates V, L.P., and Atlas Venture Associates V, Inc. pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the National Association of Securities Dealers, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as he might or could do in person thereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. [REMAINDER OF PAGE LEFT BLANK INTENTIONALLY] [SIGNATURE PAGE FOLLOWS IMMEDIATELY] Page 18 of 21 2 IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 13th day of February, 2001. /s/ Christopher J. Spray ------------------------------ Christopher J. Spray Commonwealth of Massachusetts ) ) ss: County of Suffolk ) On this 13th day of February, 2001, before me personally came Christopher J. Spray, known to me to be the person described and who executed the foregoing instrument that he acknowledged that he executed the same. [Notary Seal] /s/ Kyle Walkden ----------------------------- Notary Public My commission expires: 9/9/05 Page 19 of 21 3 IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 13th day of February, 2001. /s/ Jean Francois Formela ------------------------------ Jean Francois Formela Commonwealth of Massachusetts ) ) ss: County of Suffolk ) On this 13th day of February, 2001, before me personally came Jean-Francois Formela, known to me to be the person described and who executed the foregoing instrument that he acknowledged that he executed the same. [Notary Seal] /s/ Kyle Walkden ----------------------------- Notary Public My commission expires: 9/9/05 Page 20 of 21 4 IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 13th day of February, 2001. /s/ Ronald Nordin ------------------------------ Ronald Nordin Commonwealth of Massachusetts ) ) ss: County of Suffolk ) On this 13th day of February, 2001, before me personally came Ronald Nordin, known to me to be the person described and who executed the foregoing instrument that he acknowledged that he executed the same. [Notary Seal] /s/ Kyle Walkden ----------------------------- Notary Public My commission expires: 9/9/05 Page 21 of 21 -----END PRIVACY-ENHANCED MESSAGE-----